In this study, we found that BPC-157 is effective in the very low dose range and accelerates wound healing and that the wound repair process, which involves steps that include inflammation, collagen deposition, angiogenesis, development of granulation tissue, and the repair of epithelium, in bFGF- or BPC-157-treated groups was better than that in the model control group
Key Research Applications
Studies demonstrate oral BPC-157s ability to: Accelerate healing of gastric ulcers and intestinal anastomoses
The most comprehensive review to date, published in JAAOS Global Research & Reviews , reached the same conclusion: Although preclinical studies are promising, there is a current lack of clinical trials (Rahman et al., 2026)
However, full-length TB-4 is biologically fragile, expensive to synthesize, and has poor shelf stability, making it less practical for research or commercial use